2.04 USD
+0.03 (+1.49%)
2.04 USD
0 (0%)
ONVO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 534 industry peers in the Biotechnology industry. ONVO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ONVO is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ONVO has reported negative net income.
ONVO had a negative operating cash flow in the past year.
In the past 5 years ONVO always reported negative net income.
ONVO had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
ONVO's Return On Assets of -322.19% is on the low side compared to the rest of the industry. ONVO is outperformed by 94.71% of its industry peers.
ONVO's Return On Equity of -3402.47% is on the low side compared to the rest of the industry. ONVO is outperformed by 85.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -322.19% | ||
| ROE | -3402.47% | ||
| ROIC | N/A |
ROA(3y)-116.81%
ROA(5y)-91.68%
ROE(3y)-185.97%
ROE(5y)-134.22%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ONVO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ONVO does not have a ROIC to compare to the WACC, probably because it is not profitable.
ONVO has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ONVO has more shares outstanding
There is no outstanding debt for ONVO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
Based on the Altman-Z score of -137.52, we must say that ONVO is in the distress zone and has some risk of bankruptcy.
ONVO has a Altman-Z score of -137.52. This is amonst the worse of the industry: ONVO underperforms 97.18% of its industry peers.
ONVO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -137.52 |
ROIC/WACCN/A
WACC10.04%
2.3 Liquidity
ONVO has a Current Ratio of 0.72. This is a bad value and indicates that ONVO is not financially healthy enough and could expect problems in meeting its short term obligations.
ONVO's Current ratio of 0.72 is on the low side compared to the rest of the industry. ONVO is outperformed by 91.53% of its industry peers.
A Quick Ratio of 0.72 indicates that ONVO may have some problems paying its short term obligations.
With a Quick ratio value of 0.72, ONVO is not doing good in the industry: 91.36% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
ONVO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.26%, which is quite impressive.
Looking at the last year, ONVO shows a very negative growth in Revenue. The Revenue has decreased by -50.20% in the last year.
ONVO shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -48.77% yearly.
EPS 1Y (TTM)60.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-473%
Revenue 1Y (TTM)-50.2%
Revenue growth 3YN/A
Revenue growth 5Y-48.77%
Sales Q2Q%380%
3.2 Future
ONVO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.11% yearly.
The Revenue is expected to grow by 45.71% on average over the next years. This is a very strong growth
EPS Next Y96.31%
EPS Next 2Y40.15%
EPS Next 3Y25.11%
EPS Next 5YN/A
Revenue Next Year126.67%
Revenue Next 2Y63.71%
Revenue Next 3Y45.71%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ONVO. In the last year negative earnings were reported.
Also next year ONVO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ONVO's earnings are expected to grow with 25.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.15%
EPS Next 3Y25.11%
5. Dividend
5.1 Amount
ONVO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2.04
+0.03 (+1.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner Change47.73%
Ins OwnersN/A
Ins Owner Change0%
Market Cap3.47M
Revenue(TTM)122.00K
Net Income(TTM)-12.38M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.02%
Min EPS beat(2)10.83%
Max EPS beat(2)47.21%
EPS beat(4)4
Avg EPS beat(4)30.5%
Min EPS beat(4)10.83%
Max EPS beat(4)47.21%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-37.39%
Min Revenue beat(2)-46.52%
Max Revenue beat(2)-28.26%
Revenue beat(4)0
Avg Revenue beat(4)-38.8%
Min Revenue beat(4)-62.09%
Max Revenue beat(4)-18.3%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 28.43 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 9.53 | ||
| P/tB | 9.53 | ||
| EV/EBITDA | N/A |
EPS(TTM)-4.49
EYN/A
EPS(NY)-0.76
Fwd EYN/A
FCF(TTM)-5.95
FCFYN/A
OCF(TTM)-5.94
OCFYN/A
SpS0.07
BVpS0.21
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -322.19% | ||
| ROE | -3402.47% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-116.81%
ROA(5y)-91.68%
ROE(3y)-185.97%
ROE(5y)-134.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 4.71% | ||
| Cap/Sales | 10.66% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | -137.52 |
F-Score3
WACC10.04%
ROIC/WACCN/A
Cap/Depr(3y)148.6%
Cap/Depr(5y)294.16%
Cap/Sales(3y)57.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-473%
EPS Next Y96.31%
EPS Next 2Y40.15%
EPS Next 3Y25.11%
EPS Next 5YN/A
Revenue 1Y (TTM)-50.2%
Revenue growth 3YN/A
Revenue growth 5Y-48.77%
Sales Q2Q%380%
Revenue Next Year126.67%
Revenue Next 2Y63.71%
Revenue Next 3Y45.71%
Revenue Next 5YN/A
EBIT growth 1Y36.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.51%
OCF growth 3YN/A
OCF growth 5YN/A
ORGANOVO HOLDINGS INC / ONVO FAQ
What is the ChartMill fundamental rating of ORGANOVO HOLDINGS INC (ONVO) stock?
ChartMill assigns a fundamental rating of 2 / 10 to ONVO.
Can you provide the valuation status for ORGANOVO HOLDINGS INC?
ChartMill assigns a valuation rating of 1 / 10 to ORGANOVO HOLDINGS INC (ONVO). This can be considered as Overvalued.
How profitable is ORGANOVO HOLDINGS INC (ONVO) stock?
ORGANOVO HOLDINGS INC (ONVO) has a profitability rating of 0 / 10.
What is the financial health of ORGANOVO HOLDINGS INC (ONVO) stock?
The financial health rating of ORGANOVO HOLDINGS INC (ONVO) is 4 / 10.